Role of TNF-α in human female reproduction

References

• Coley WB. A preliminary note on the treatment of inoperable sarcoma by the toxic product of erysipelas. Post-graduate8, 278–286 (1893).
   Google Scholar
• Nauts HC, Fowler GA, Bogatko FH. A review of the influence of bacterial infection and of bacterial products (Coley’s toxins) on malignant tumors in man; a critical analysis of 30 inoperable cases treated by Coley’s mixed toxins, in which diagnosis was confirmed by microscopic examination selected for special study. Acta Med. Scand. Suppl.276, 1–103 (1953).
   PubMedGoogle Scholar
• Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc. Natl Acad. Sci. USA72(9), 3666–3670 (1975).
   PubMed Web of Science ®Google Scholar
• Matthews N, Watkins JF. Tumour-necrosis factor from the rabbit. I. Mode of action, specificity and physicochemical properties. Br. J. Cancer38(2), 302–309 (1978).
   PubMed Web of Science ®Google Scholar
• Matthews N. Production of an anti-tumour cytotoxin by human monocytes. Immunology44(1), 135–142 (1981).
   PubMed Web of Science ®Google Scholar
• Green S, Dobrjansky A, Carswell EA et al. Partial purification of a serum factor that causes necrosis of tumors. Proc. Natl Acad. Sci. USA73(2), 381–385 (1976).
   PubMed Web of Science ®Google Scholar
• Pennica D, Nedwin GE, Hayflick JS et al. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature312(5996), 724–729 (1984).
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Kohr WJ, Hass PE et al. Human tumor necrosis factor. Production, purification, and characterization. J. Biol. Chem.260(4), 2345–2354 (1985).
   PubMed Web of Science ®Google Scholar
• Pennica D, Hayflick JS, Bringman TS, Palladino MA, Goeddel DV. Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. Proc. Natl Acad. Sci. USA82(18), 6060–6064 (1985).
   PubMed Web of Science ®Google Scholar
• Shirai T, Yamaguchi H, Ito H, Todd CW, Wallace RB. Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor. Nature313(6005), 803–806 (1985).
   PubMed Web of Science ®Google Scholar
• Fransen L, Muller R, Marmenout A et al. Molecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expression. Nucleic Acids Res.13(12), 4417–4429 (1985).
   PubMed Web of Science ®Google Scholar
• Hunt JS, Atherton RA, Pace JL. Differential responses of rat trophoblast cells and embryonic fibroblasts to cytokines that regulate proliferation and class I MHC antigen expression. J. Immunol.145(1), 184–189 (1990).
   PubMed Web of Science ®Google Scholar
• Spies T, Bresnahan M, Strominger JL. Human major histocompatibility complex contains a minimum of 19 genes between the complement cluster and HLA-B. Proc. Natl. Acad. Sci. USA86(22), 8955–8958 (1989).
   PubMed Web of Science ®Google Scholar
• Nedwin GE, Naylor SL, Sakaguchi AY et al. Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. Nucleic Acids Res.13(17), 6361–6373 (1985).
   PubMed Web of Science ®Google Scholar
• Jaattela M, Ilvesmaki V, Voutilainen R, Stenman UH, Saksela E. Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology128(1), 623–629 (1991).
   PubMed Web of Science ®Google Scholar
• Jaattela M, Pinola M, Saksela E. Heat shock inhibits the cytotoxic action of TNF-α in tumor cells but does not alter its noncytotoxic actions in endothelial and adrenal cells. Lymphokine Cytokine Res.10(1–2), 119–125 (1991).
   PubMedGoogle Scholar
• Beutler B, Cerami A. The biology of cachectin/TNF – a primary mediator of the host response. Annu. Rev. Immunol.7, 625–655 (1989).
   PubMed Web of Science ®Google Scholar
• Smith RA, Baglioni C. The active form of tumor necrosis factor is a trimer. J. Biol. Chem.262(15), 6951–6954 (1987).
   PubMed Web of Science ®Google Scholar
• Wingfield P, Pain RH, Craig S. Tumour necrosis factor is a compact trimer. FEBS Lett.211(2), 179–184 (1987).
   PubMed Web of Science ®Google Scholar
• Fiers W, Brouckaert P, Goldberg AL et al. Structure–function relationship of tumour necrosis factor and its mechanism of action. Ciba Found. Symp.131, 109–123 (1987).
   PubMedGoogle Scholar
• Eck MJ, Sprang SR. The structure of tumor necrosis factor-α at 2.6 Å resolution. Implications for receptor binding. J. Biol. Chem.264(29), 17595–17605 (1989).
   PubMed Web of Science ®Google Scholar
• Kriegler M, Perez C, DeFay K, Albert I, Lu SD. A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell53(1), 45–53 (1988).
   PubMed Web of Science ®Google Scholar
• Luettig B, Decker T, Lohmann-Matthes ML. Evidence for the existence of two forms of membrane tumor necrosis factor: an integral protein and a molecule attached to its receptor. J. Immunol.143(12), 4034–4038 (1989).
   PubMed Web of Science ®Google Scholar
• Van O, X, Tavernier J, Fiers W. Structure–activity studies of human tumour necrosis factors. Protein Eng.7(1), 5–22 (1994).
   PubMedGoogle Scholar
• Cuturi MC, Murphy M, Costa-Giomi MP, Weinmann R, Perussia B, Trinchieri G. Independent regulation of tumor necrosis factor and lymphotoxin production by human peripheral blood lymphocytes. J. Exp. Med.165(6), 1581–1594 (1987).
   PubMed Web of Science ®Google Scholar
• Sung SS, Jung LK, Walters JA, Chen W, Wang CY, Fu SM. Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells. J. Exp. Med.168(5), 1539–1551 (1988).
   PubMed Web of Science ®Google Scholar
• Sung SS, Bjorndahl JM, Wang CY, Kao HT, Fu SM. Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody. J. Exp. Med.167(3), 937–953 (1988).
   PubMed Web of Science ®Google Scholar
• Spriggs D, Imamura K, Rodriguez C, Horiguchi J, Kufe DW. Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line. Proc. Natl Acad. Sci. USA84(18), 6563–6566 (1987).
   PubMed Web of Science ®Google Scholar
• Peters PM, Ortaldo JR, Shalaby MR et al. Natural killer-sensitive targets stimulate production of TNF-α but not TNF-β (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes. J. Immunol.137(8), 2592–2598 (1986).
   PubMed Web of Science ®Google Scholar
• Young JD, Liu CC, Butler G, Cohn ZA, Galli SJ. Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor. Proc. Natl Acad. Sci. USA84(24), 9175–9179 (1987).
   PubMed Web of Science ®Google Scholar
• Chiang CS, McBride WH. Radiation enhances tumor necrosis factor α production by murine brain cells. Brain Res.566(1–2), 265–269 (1991).
   PubMed Web of Science ®Google Scholar
• Kutteh WH, Rainey WE, Carr BR. Glucocorticoids inhibit lipopolysaccharide-induced production of tumor necrosis factor-α by human fetal Kupffer cells. J. Clin. Endocrinol. Metab.73(2), 296–301 (1991).
   PubMed Web of Science ®Google Scholar
• Kutteh WH, Rainey WE, Beutler B, Carr BR. Tumor necrosis factor-α and interleukin-1 β production by human fetal Kupffer cells. Am. J. Obstet. Gynecol.165(1), 112–120 (1991).
   PubMed Web of Science ®Google Scholar
• Strieter RM, Remick DG, Lynch JP 3rd et al. Differential regulation of tumor necrosis factor-α in human alveolar macrophages and peripheral blood monocytes: a cellular and molecular analysis. Am. J. Respir. Cell Mol. Biol.1(1), 57–63 (1989).
   PubMed Web of Science ®Google Scholar
• Stallmach T, Hebisch G, Joller H, Kolditz P, Engelmann M. Expression pattern of cytokines in the different compartments of the feto–maternal unit under various conditions. Reprod. Fertil. Dev.7(6), 1573–1580 (1995).
   PubMed Web of Science ®Google Scholar
• Han HM, Kolhatkar AA, Marino MW, Manchester KM, Donner DB. Identification, characterization, and homologous up-regulation of latent (cryptic) receptors for tumor necrosis factor-α in rat liver plasma membranes. J. Biol. Chem.265(30), 18590–18594 (1990).
   PubMed Web of Science ®Google Scholar
• Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science232(4753), 977–980 (1986).
   PubMed Web of Science ®Google Scholar
• Matthews N. Tumour-necrosis factor from the rabbit. V. Synthesis in vitro by mononuclear phagocytes from various tissues of normal and BCG-injected rabbits. Br. J. Cancer44(3), 418–424 (1981).
   PubMed Web of Science ®Google Scholar
• Kovacs EJ, Radzioch D, Young HA, Varesio L. Differential inhibition of IL-1 and TNF-α mRNA expression by agents which block second messenger pathways in murine macrophages. J. Immunol.141(9), 3101–3105 (1988).
   PubMed Web of Science ®Google Scholar
• Takasuka N, Matsuura K, Yamamoto S, Akagawa KS. Suppression of TNF-α mRNA expression in LPS-primed macrophages occurs at the level of nuclear factor-κB activation, but not at the level of protein kinase C or CD14 expression. J. Immunol.154(9), 4803–4812 (1995).
   PubMed Web of Science ®Google Scholar
• Akira S, Isshiki H, Sugita T et al. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J.9(6), 1897–1906 (1990).
   PubMed Web of Science ®Google Scholar
• Shakhov AN, Collart MA, Vassalli P, Nedospasov SA, Jongeneel CV. κB-type enhancers are involved in lipopolysaccharide-mediated transcriptional activation of the tumor necrosis factor α gene in primary macrophages. J. Exp. Med.171(1), 35–47 (1990).
   PubMed Web of Science ®Google Scholar
• Beutler BA, Milsark IW, Cerami A. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J. Immunol.135(6), 3972–3977 (1985).
   PubMed Web of Science ®Google Scholar
• Cockfield SM, Ramassar V, Halloran PF. Regulation of IFN-γ and tumor necrosis factor-α expression in vivo. Effects of cycloheximide and cyclosporine in normal and lipopolysaccharide-treated mice. J. Immunol.150(2), 342–352 (1993).
   PubMed Web of Science ®Google Scholar
• Satomi N, Haranaka K, Kunii O. Research on the production site of tumor necrosis factor (TNF). Jpn. J. Exp. Med.51(6), 317–322 (1981).
   PubMedGoogle Scholar
• Gifford GE, Flick DA. Natural production and release of tumour necrosis factor. Ciba Found. Symp.131, 3–20 (1987).
   PubMedGoogle Scholar
• de Kossodo S, Critico B, Grau GE. Modulation of the transcripts for tumor necrosis factor-α and its receptors in vivo. Eur. J. Immunol.24(3), 769–772 (1994).
   PubMed Web of Science ®Google Scholar
• Philip R, Epstein LB. Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interferon and interleukin-1. Nature323(6083), 86–89 (1986).
   PubMed Web of Science ®Google Scholar
• Bethea JR, Gillespie GY, Benveniste EN. Interleukin-1 β induction of TNF-α gene expression: involvement of protein kinase C. J. Cell Physiol.152(2), 264–273 (1992).
   PubMed Web of Science ®Google Scholar
• Kasid A, Director EP, Stovroff MC, Lotze MT, Rosenberg SA. Cytokine regulation of tumor necrosis factor-α and -β (lymphotoxin)-messenger RNA expression in human peripheral blood mononuclear cells. Cancer Res.50(16), 5072–5076 (1990).
   PubMed Web of Science ®Google Scholar
• Hensel G, Mannel DN, Pfizenmaier K, Kronke M. Autocrine stimulation of TNF-α mRNA expression in HL-60 cells. Lymphokine Res.6(2), 119–125 (1987).
   PubMedGoogle Scholar
• Aderka D, Le JM, Vilcek J. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J. Immunol.143(11), 3517–3523 (1989).
   PubMed Web of Science ®Google Scholar
• Ralph P, Nakoinz I, Sampson-Johannes A et al. IL-10, T lymphocyte inhibitor of human blood cell production of IL-1 and tumor necrosis factor. J. Immunol.148(3), 808–814 (1992).
   PubMed Web of Science ®Google Scholar
• Gearing AJ, Beckett P, Christodoulou M et al. Matrix metalloproteinases and processing of pro-TNF-α. J. Leukoc. Biol.57(5), 774–777 (1995).
   PubMed Web of Science ®Google Scholar
• Kunkel SL, Wiggins RC, Chensue SW, Larrick J. Regulation of macrophage tumor necrosis factor production by prostaglandin E2. Biochem. Biophys. Res. Commun.137(1), 404–410 (1986).
   PubMed Web of Science ®Google Scholar
• Hohmann HP, Remy R, Brockhaus M, van Loon AP. Two different cell types have different major receptors for human tumor necrosis factor (TNF α). J. Biol. Chem.264(25), 14927–14934 (1989).
   PubMed Web of Science ®Google Scholar
• Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl Acad. Sci. USA87(8), 3127–3131 (1990).
   PubMed Web of Science ®Google Scholar
• Tartaglia LA, Goeddel DV. Two TNF receptors. Immunol. Today13(5), 151–153 (1992).
   PubMedGoogle Scholar
• Wong GH, Tartaglia LA, Lee MS, Goeddel DV. Antiviral activity of tumor necrosis factor is signaled through the 55-kDa type I TNF receptor [corrected]. J. Immunol.149(10), 3350–3353 (1992).
   PubMed Web of Science ®Google Scholar
• Banner DW, D’Arcy A, Janes W et al. Crystal structure of the soluble human 55 kD TNF receptor–human TNF β complex: implications for TNF receptor activation. Cell73(3), 431–445 (1993).
   PubMed Web of Science ®Google Scholar
• Tchorzewski H, Zeman K, Paleolog E et al. The effects of tumor necrosis factor (TNF) derivatives on TNF receptors. Cytokine5(2), 125–132 (1993).
   PubMed Web of Science ®Google Scholar
• Fiers W. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett.285(2), 199–212 (1991).
   PubMed Web of Science ®Google Scholar
• Fiers W, Beyaert R, Boone E et al. TNF-induced intracellular signaling leading to gene induction or to cytotoxicity by necrosis or by apoptosis. J. Inflamm.47(1–2), 67–75 (1995).
   PubMedGoogle Scholar
• Porteu F, Hieblot C. Tumor necrosis factor induces a selective shedding of its p75 receptor from human neutrophils. J. Biol. Chem.269(4), 2834–2840 (1994).
   PubMed Web of Science ®Google Scholar
• Mosselmans R, Hepburn A, Dumont JE, Fiers W, Galand P. Endocytic pathway of recombinant murine tumor necrosis factor in L-929 cells. J. Immunol.141(9), 3096–3100 (1988).
   PubMed Web of Science ®Google Scholar
• Leeuwenberg JF, van Tits LJ, Jeunhomme TM, Buurman WA. Evidence for exclusive role in signalling of tumour necrosis factor p55 receptor and a potentiating function of p75 receptor on human endothelial cells. Cytokine7(5), 457–462 (1995).
   PubMed Web of Science ®Google Scholar
• Bemelmans MH, Gouma DJ, Buurman WA. LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-γ. J. Immunol.151(10), 5554–5562 (1993).
   PubMed Web of Science ®Google Scholar
• Fernandez-Botran R. Soluble cytokine receptors: their role in immunoregulation. FASEB J.5(11), 2567–2574 (1991).
   PubMed Web of Science ®Google Scholar
• Erikstein BK, Smeland EB, Blomhoff HK et al. Independent regulation of 55-kDa and 75-kDa tumor necrosis factor receptors during activation of human peripheral blood B lymphocytes. Eur. J. Immunol.21(4), 1033–1037 (1991).
   PubMed Web of Science ®Google Scholar
• Winzen R, Wallach D, Kemper O, Resch K, Holtmann H. Selective up-regulation of the 75-kDa tumor necrosis factor (TNF) receptor and its mRNA by TNF and IL-1. J. Immunol.150(10), 4346–4353 (1993).
   PubMed Web of Science ®Google Scholar
• Heller RA, Song K, Fan N, Chang DJ. The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell70(1), 47–56 (1992).
   PubMed Web of Science ®Google Scholar
• Barbara JA, Smith WB, Gamble JR et al. Dissociation of TNF-α cytotoxic and proinflammatory activities by p55 receptor- and p75 receptor-selective TNF-α mutants. EMBO J.13(4), 843–850 (1994).
   PubMed Web of Science ®Google Scholar
• Vandenabeele P, Declercq W, Beyaert R, Fiers W. Two tumour necrosis factor receptors: structure and function. Trends Cell Biol.5(10), 392–399 (1995).
   PubMed Web of Science ®Google Scholar
• Terranova PF, Hunter VJ, Roby KF, Hunt JS. Tumor necrosis factor-α in the female reproductive tract. Proc. Soc. Exp. Biol. Med.209(4), 325–342 (1995).
   PubMed Web of Science ®Google Scholar
• Wang LJ, Brannstrom M, Robertson SA, Norman RJ. Tumor necrosis factor α in the human ovary: presence in follicular fluid and effects on cell proliferation and prostaglandin production. Fertil. Steril.58(5), 934–940 (1992).
   PubMed Web of Science ®Google Scholar
• Yan Z, Hunter V, Weed J, Hutchison S, Lyles R, Terranova P. Tumor necrosis factor-α alters steroidogenesis and stimulates proliferation of human ovarian granulosal cells in vitro. Fertil. Steril.59(2), 332–338 (1993).
   PubMed Web of Science ®Google Scholar
• Zhao Y, Burbach JA, Roby KF, Terranova PF, Brannian JD. Macrophages are the major source of tumor necrosis factor α in the porcine corpus luteum. Biol. Reprod.59(6), 1385–1391 (1998).
   PubMed Web of Science ®Google Scholar
• Terranova P, Roby KF, Sancho-Tello M, Weed J, Lyles R. Tumor necrosis factor α: localization and actions within the prevovulatory follicle. In: Growth Factors in Reproduction. Schomberg D (Ed.). Springer-Verlag, Heidelberg, Germany 63–78 (1991).
   Google Scholar
• Clinton TK, Roby KF, Lyles R, Terranova P. Tumor necrosis factor α and prolactin increase hCG binding in human granulosa cells: differential interaction with hCG-stimulated progesterone secretion. In: Signaling Mechanisms and Gene Expression in the Ovary. Gibori G (Ed.). Springer-Verlag, Heidelberg, Germany 459–466 (1991).
   Google Scholar
• Rice VM, Limback SD, Roby KF, Terranova PF. Changes in circulating and ovarian concentrations of bioactive tumour necrosis factor α during the first ovulation at puberty in rats and in gonadotrophin-treated immature rats. J. Reprod. Fertil.113(2), 337–341 (1998).
   PubMedGoogle Scholar
• Hillensjo T, Magnusson C, Svensson U, Thelander H. Effect of luteinizing hormone and follicle-stimulating hormone on progesterone synthesis by cultured rat cumulus cells. Endocrinology108(5), 1920–1924 (1981).
   PubMed Web of Science ®Google Scholar
• Butcher RL, Collins WE, Fugo NW. Altered secretion of gonadotropins and steroids resulting from delayed ovulation in the rat. Endocrinology96(3), 576–586 (1975).
   PubMed Web of Science ®Google Scholar
• Butcher RL, Pope RS. Role of estrogen during prolonged estrous cycles of the rat on subsequent embryonic death or development. Biol. Reprod.21(2), 491–495 (1979).
   PubMed Web of Science ®Google Scholar
• Bagavandoss P, Wiggins RC, Kunkel SL, Remick DG, Keyes PL. Tumor necrosis factor production and accumulation of inflammatory cells in the corpus luteum of pseudopregnancy and pregnancy in rabbits. Biol. Reprod.42(2), 367–376 (1990).
   PubMed Web of Science ®Google Scholar
• Greenfeld CR, Roby KF, Pepling ME, Babus JK, Terranova PF, Flaws JA. Tumor necrosis factor (TNF) receptor type 2 is an important mediator of TNF α function in the mouse ovary. Biol. Reprod.76(2), 224–231 (2007).
   PubMed Web of Science ®Google Scholar
• Zolti M, Meirom R, Shemesh M et al. Granulosa cells as a source and target organ for tumor necrosis factor-α. FEBS Lett.261(2), 253–255 (1990).
   PubMed Web of Science ®Google Scholar
• Benyo DF, Pate JL. Tumor necrosis factor-α alters bovine luteal cell synthetic capacity and viability. Endocrinology130(2), 854–860 (1992).
   PubMed Web of Science ®Google Scholar
• Adashi EY, Resnick CE, Packman JN, Hurwitz A, Payne DW. Cytokine-mediated regulation of ovarian function: tumor necrosis factor α inhibits gonadotropin-supported progesterone accumulation by differentiating and luteinized murine granulosa cells. Am. J. Obstet. Gynecol.162(4), 889–896 (1990).
   PubMed Web of Science ®Google Scholar
• Ji I, Slaughter RG, Ellis JA, Ji TH, Murdoch WJ. Analyses of ovine corpora lutea for tumor necrosis factor mRNA and bioactivity during prostaglandin-induced luteolysis. Mol. Cell. Endocrinol.81(1–3), 77–80 (1991).
   PubMed Web of Science ®Google Scholar
• Zolti M, Ben Rafael Z, Meirom R et al. Cytokine involvement in oocytes and early embryos. Fertil. Steril.56(2), 265–272 (1991).
   PubMed Web of Science ®Google Scholar
• Hunt JS, Chen HL, Hu XL, Tabibzadeh S. Tumor necrosis factor-α messenger ribonucleic acid and protein in human endometrium. Biol. Reprod.47(1), 141–147 (1992).
   PubMed Web of Science ®Google Scholar
• Philippeaux MM, Piguet PF. Expression of tumor necrosis factor-α and its mRNA in the endometrial mucosa during the menstrual cycle. Am. J. Pathol.143(2), 480–486 (1993).
   PubMed Web of Science ®Google Scholar
• Giroir BP, Peppel K, Silva M, Beutler B. The biosynthesis of tumor necrosis factor during pregnancy: studies with a CAT reporter transgene and TNF inhibitors. Eur. Cytokine Netw.3(6), 533–538 (1992).
   PubMedGoogle Scholar
• Roby KF, Hunt JS. Mouse endometrial tumor necrosis factor-α messenger ribonucleic acid and protein: localization and regulation by estradiol and progesterone. Endocrinology135(6), 2780–2789 (1994).
   PubMed Web of Science ®Google Scholar
• Clark DA. Should anti-TNF-α therapy be offered to patients with infertility and recurrent spontaneous abortion? Am. J. Reprod. Immunol.61(2), 107–112 (2009).
   PubMed Web of Science ®Google Scholar
• Menon R, Velez DR, Morgan N, Lombardi SJ, Fortunato SJ, Williams SM. Genetic regulation of amniotic fluid TNF-α and soluble TNF receptor concentrations affected by race and preterm birth. Hum. Genet.124(3), 243–253 (2008).
   PubMed Web of Science ®Google Scholar
• Jacobsson B, Aaltonen R, Rantakokko-Jalava K, Morken NH, Alanen A. Quantification of Ureaplasma urealyticum DNA in the amniotic fluid from patients in PTL and pPROM and its relation to inflammatory cytokine levels. Acta Obstet. Gynecol. Scand.88(1), 63–70 (2009).
   PubMed Web of Science ®Google Scholar
• Leal AM, Poon LC, Frisova V, Veduta A, Nicolaides KH. First-trimester maternal serum tumor necrosis factor receptor-1 and pre-eclampsia. Ultrasound Obstet. Gynecol.33(2), 135–141 (2009).
   PubMed Web of Science ®Google Scholar
• King A. Uterine leukocytes and decidualization. Hum. Reprod. Update6(1), 28–36 (2000).
   PubMed Web of Science ®Google Scholar
• Raghupathy R. Pregnancy: success and failure within the Th1/Th2/Th3 paradigm. Semin. Immunol.13(4), 219–227 (2001).
   PubMed Web of Science ®Google Scholar
• Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today17(3), 138–146 (1996).
   PubMedGoogle Scholar
• Coffman RL, Romagnani S. Redirection of Th1 and Th2 Responses. Springer-Verlag, Heidelberg, Germany (1999).
   Google Scholar
• Eisenstein EM, Williams CB. The Treg/Th17 cell balance: a new paradigm for autoimmunity. Pediatr. Res. (2009) (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal–fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol. Today14(7), 353–356 (1993).
   PubMedGoogle Scholar
• Piccinni MP, Giudizi MG, Biagiotti R et al. Progesterone favors the development of human T helper cells producing Th2-type cytokines and promotes both IL-4 production and membrane CD30 expression in established Th1 cell clones. J. Immunol.155(1), 128–133 (1995).
   PubMed Web of Science ®Google Scholar
• Kelly RW, Carr GG, Elliott CL, Tulppala M, Critchley HO. Prostaglandin and cytokine release by trophoblastic villi. Hum. Reprod.10(12), 3289–3292 (1995).
   PubMed Web of Science ®Google Scholar
• Kelly RW, Critchley HO. A T-helper-2 bias in decidua: the prostaglandin contribution of the macrophage and trophoblast. J. Reprod. Immunol.33(3), 181–187 (1997).
   PubMed Web of Science ®Google Scholar
• Robertson SA, Seamark RF, Guilbert LJ, Wegmann TG. The role of cytokines in gestation. Crit. Rev. Immunol.14(3–4), 239–292 (1994).
   PubMed Web of Science ®Google Scholar
• Vince GS, Johnson PM. Is there a Th2 bias in human pregnancy? J. Reprod. Immunol.32(2), 101–104 (1996).
   PubMed Web of Science ®Google Scholar
• Sacks GP, Clover LM, Bainbridge DR, Redman CW, Sargent IL. Flow cytometric measurement of intracellular Th1 and Th2 cytokine production by human villous and extravillous cytotrophoblast. Placenta22(6), 550–559 (2001).
   PubMed Web of Science ®Google Scholar
• Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol. Today18(10), 478–482 (1997).
   PubMedGoogle Scholar
• Clark DA, Arck PC, Chaouat G. Why did your mother reject you? Immunogenetic determinants of the response to environmental selective pressure expressed at the uterine level. Am. J. Reprod. Immunol.41(1), 5–22 (1999).
   PubMed Web of Science ®Google Scholar
• Hill JA, Polgar K, Harlow BL, Anderson DJ. Evidence of embryo- and trophoblast-toxic cellular immune response(s) in women with recurrent spontaneous abortion. Am. J. Obstet. Gynecol.166(4), 1044–1052 (1992).
   PubMed Web of Science ®Google Scholar
• Chaouat G, Menu E, Clark DA, Dy M, Minkowski M, Wegmann TG. Control of fetal survival in CBA × DBA/2 mice by lymphokine therapy. J. Reprod. Fertil.89(2), 447–458 (1990).
   PubMedGoogle Scholar
• Haimovici F, Hill JA, Anderson DJ. The effects of soluble products of activated lymphocytes and macrophages on blastocyst implantation events in vitro. Biol. Reprod.44(1), 69–75 (1991).
   PubMed Web of Science ®Google Scholar
• Yui J, Garcia-Lloret M, Wegmann TG, Guilbert LJ. Cytotoxicity of tumour necrosis factor-α and γ-interferon against primary human placental trophoblasts. Placenta15(8), 819–835 (1994).
   PubMed Web of Science ®Google Scholar
• Clark DA, Yu G, Arck PC, Levy GA, Gorczynski RM. MD-1 is a critical part of the mechanism causing Th1-cytokine-triggered murine fetal loss syndrome. Am. J. Reprod. Immunol.49(5), 297–307 (2003).
   PubMed Web of Science ®Google Scholar
• Clark DA, Chaouat G, Arck PC, Mittruecker HW, Levy GA. Cytokine-dependent abortion in CBA × DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase [correction of prothombinase]. J. Immunol.160(2), 545–549 (1998).
   PubMed Web of Science ®Google Scholar
• Clark DA, Ding JW, Chaouat G, Coulam CB, August C, Levy GA. The emerging role of immunoregulation of fibrinogen-related procoagulant Fgl2 in the success or spontaneous abortion of early pregnancy in mice and humans. Am. J. Reprod. Immunol.42(1), 37–43 (1999).
   PubMed Web of Science ®Google Scholar
• Romero R, Manogue KR, Mitchell MD et al. Infection and labor. IV. Cachectin-tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am. J. Obstet. Gynecol.161(2), 336–341 (1989).
   PubMed Web of Science ®Google Scholar
• Casey ML, Cox SM, Beutler B, Milewich L, MacDonald PC. Cachectin/tumor necrosis factor-α formation in human decidua. Potential role of cytokines in infection-induced preterm labor. J. Clin. Invest.83(2), 430–436 (1989).
   PubMed Web of Science ®Google Scholar
• Arck P, Dietl J, Clark D. From the decidual cell internet: trophoblast-recognizing T cells. Biol. Reprod.60(2), 227–233 (1999).
   PubMed Web of Science ®Google Scholar
• Guilbert LJ. There is a bias against type 1 (inflammatory) cytokine expression and function in pregnancy. J. Reprod. Immunol.32(2), 105–110 (1996).
   PubMed Web of Science ®Google Scholar
• Yelavarthi KK, Chen HL, Yang YP, Cowley BD Jr, Fishback JL, Hunt JS. Tumor necrosis factor-α mRNA and protein in rat uterine and placental cells. J. Immunol.146(11), 3840–3848 (1991).
   PubMed Web of Science ®Google Scholar
• Hunt JS, Chen HL, Hu XL, Pollard JW. Normal distribution of tumor necrosis factor-α messenger ribonucleic acid and protein in the uteri, placentas, and embryos of osteopetrotic (op/op) mice lacking colony-stimulating factor-1. Biol. Reprod.49(3), 441–452 (1993).
   PubMed Web of Science ®Google Scholar
• Chen HL, Yang YP, Hu XL, Yelavarthi KK, Fishback JL, Hunt JS. Tumor necrosis factor α mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am. J. Pathol.139(2), 327–335 (1991).
   PubMed Web of Science ®Google Scholar
• Vince G, Shorter S, Starkey P et al. Localization of tumour necrosis factor production in cells at the materno/fetal interface in human pregnancy. Clin. Exp. Immunol.88(1), 174–180 (1992).
   PubMed Web of Science ®Google Scholar
• Tartakovsky B, Ben Yair E. Cytokines modulate preimplantation development and pregnancy. Dev. Biol.146(2), 345–352 (1991).
   PubMed Web of Science ®Google Scholar
• Hunt JS. Expression and regulation of the tumour necrosis factor-α gene in the female reproductive tract. Reprod. Fertil. Dev.5(2), 141–153 (1993).
   PubMed Web of Science ®Google Scholar
• Li Y, Matsuzaki N, Masuhiro K et al. Trophoblast-derived tumor necrosis factor-α induces release of human chorionic gonadotropin using interleukin-6 (IL-6) and IL-6-receptor-dependent system in the normal human trophoblasts. J. Clin. Endocrinol. Metab.74(1), 184–191 (1992).
   PubMed Web of Science ®Google Scholar
• Yang Y, Yelavarthi KK, Chen HL, Pace JL, Terranova PF, Hunt JS. Molecular, biochemical, and functional characteristics of tumor necrosis factor-α produced by human placental cytotrophoblastic cells. J. Immunol.150(12), 5614–5624 (1993).
   PubMed Web of Science ®Google Scholar
• Knofler M, Mosl B, Bauer S, Griesinger G, Husslein P. TNF-α/TNFRI in primary and immortalized first trimester cytotrophoblasts. Placenta21(5–6), 525–535 (2000).
   PubMed Web of Science ®Google Scholar
• Yelavarthi KK, Hunt JS. Analysis of p60 and p80 tumor necrosis factor-α receptor messenger RNA and protein in human placentas. Am. J. Pathol.143(4), 1131–1141 (1993).
   PubMed Web of Science ®Google Scholar
• Rutherford MS, Schook LB. Differential immunocompetence of macrophages derived using macrophage or granulocyte–macrophage colony-stimulating factor. J. Leukoc. Biol.51(1), 69–76 (1992).
   PubMed Web of Science ®Google Scholar
• Alon R, Cahalon L, Hershkoviz R et al. TNF-α binds to the N-terminal domain of fibronectin and augments the β 1-integrin-mediated adhesion of CD4+ T lymphocytes to the glycoprotein. J. Immunol.152(3), 1304–1313 (1994).
   PubMed Web of Science ®Google Scholar
• Monzon-Bordonaba F, Vadillo-Ortega F, Feinberg RF. Modulation of trophoblast function by tumor necrosis factor-α: a role in pregnancy establishment and maintenance? Am. J. Obstet. Gynecol.187(6), 1574–1580 (2002).
   PubMed Web of Science ®Google Scholar
• Kohchi C, Noguchi K, Tanabe Y, Mizuno D, Soma G. Constitutive expression of TNF-α and -β genes in mouse embryo: roles of cytokines as regulator and effector on development. Int. J. Biochem.26(1), 111–119 (1994).
   PubMedGoogle Scholar
• Yelavarthi KK, Hunt JS. Analysis of p60 and p80 tumor necrosis factor-α receptor messenger RNA and protein in human placentas. Am. J. Pathol.143(4), 1131–1141 (1993).
   PubMed Web of Science ®Google Scholar
• de Kossodo S, Grau GE, Daneva T et al. Tumor necrosis factor α is involved in mouse growth and lymphoid tissue development. J. Exp. Med.176(5), 1259–1264 (1992).
   PubMed Web of Science ®Google Scholar
• Toder V, Fein A, Carp H, Torchinsky A. TNF-α in pregnancy loss and embryo maldevelopment: a mediator of detrimental stimuli or a protector of the fetoplacental unit? J. Assist. Reprod. Genet.20(2), 73–81 (2003).
   PubMed Web of Science ®Google Scholar
• Baud V, Karin M. Signal transduction by tumor necrosis factor and its relatives. Trends Cell Biol.11(9), 372–377 (2001).
   PubMed Web of Science ®Google Scholar
• Kokawa K, Shikone T, Nakano R. Apoptosis in human chorionic villi and decidua during normal embryonic development and spontaneous abortion in the first trimester. Placenta19(1), 21–26 (1998).
   PubMed Web of Science ®Google Scholar
• Flein A, Kostina E, Savion S et al. Expression of tumor necrosis factor-α in the pregnant uterus of diabetic mice: effect of maternal immunopotentiation. Am. J. Reprod. Immunol.46(2), 161–168 (2001).
   PubMed Web of Science ®Google Scholar